New Immune-Boosting strategy tested in aggressive breast cancer
NCT ID NCT04373031
Summary
This study is testing whether adding different immune-boosting drugs before standard chemotherapy and immunotherapy can improve treatment for triple negative breast cancer. The trial involves 12 participants with early-stage breast cancer who will receive treatment before surgery. Researchers want to see if these combinations help eliminate more cancer cells and improve immune system response against the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
Conditions
Explore the condition pages connected to this study.